摘要
目的:观察蛇丹合剂临床疗效和安全性,探讨中药治疗痤疮及其评价的方法学。方法:采用随机、阳性药物对照,按盲法操作的方法客观评价疗效及安全性,采用DME方法,参照GCP临床研究规范进行中医药临床疗效评价和临床试验的方法学探讨。结果:184例随机分配至治疗组92例,对照组92例,治疗组采用蛇丹合剂,对照组口服清热暗疮片,疗程8周。治疗组痊愈5例(5.43%),显效5例,有效62例,总有效率78.26%;对照组痊愈1例,显效1例,有效41例,总有效率46.74%。两组总有效率差异显著(P=0.005)。治疗组1例发生不良事件且与治疗药物无关,对照组7例发生不良事件(P<0.05)。治疗组40例病人治疗前后进行安全性检测,结果表明,采用蛇丹合剂治疗8周,对血、尿常规,肝肾功能没有明显影响,安全性较好。结论:蛇丹合剂是治疗湿热蕴结型痤疮的安全有效的方剂,值得临床推广应用。
Objective :To evaluate the effectivity and safety of Shedan Mixture on 184 aene patients and approach methodology of clinical trial and evaluation. Methods : It is a randomized controlled clinical trial which evaluate the effectivity and safety of Shedan Mixture objectively. Using DME (design, measure, evaluation)method approach methodology of clinical trial and evaluation. Results :184 patients were randomly divided to treatment group and control group. Total effective rate of two groups is 78. 26% ,46.74% respectively( P = 0. 005). Adverse effects occurs to 1 patient in treatment group but 7 in control group ( P 〈 0. 05). 40 patients in treatment group were checked up on blood, urine and function of liver and kidney pretreatment and posttreatment, No abnormality correlated to Shedan Mixture were found. Conclusion :Shendan Mixture is an effective and safety therapeutic method which is worthy of generalizing and utilizing.
出处
《辽宁中医杂志》
CAS
北大核心
2007年第5期587-589,共3页
Liaoning Journal of Traditional Chinese Medicine
基金
首都发展医学基金(首发03-Ⅲ-19)